HOME Top Market Reports Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: January 2016
Report Code: BT 2711

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


Existing opportunities and huge research investments by several key players in microbiome arena facilitate human microbiome market to gain market traction

The human microbiome market is an emerging market with abundant opportunities. The market is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. The market potential is quite large, considering the structure of the market. The factors driving this market include rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate. The factors restraining this market include lack of comprehensive research to assist in market pull, lack of awareness among the population regarding the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics.

The human microbiome market is divided into three major segments, namely, application, disease, and product. Different products in the market and its usage are expected to contribute to the growth of the overall market. Increase in lifestyle diseases will help the market to proliferate, while the application segment is also considered as a major driving factor for the market. Also, the human microbiome research spending market is broadly segmented by product and technology.

Europe is expected to command as a resourceful market with the largest share in the human microbiome market and expected to grow within the coming years. The primary growth driver for Europe is the aging population size and the increasing lifestyle diseases. The increasing need among the population to stay fit and have a healthy lifestyle has leveraged the use of prebiotics and probiotics. The consumers seek for a wider variety of food and beverages that contain beneficial probiotics and prebiotics and other food supplements that helps to maintain microbiome balance. APAC accounted for the second-largest market share and will be the main focus of the market in the coming five years that will register high-growth rates for all the segments. The U.S. market at present is a niche market due to the lack of awareness among the population regarding the beneficial usage of prebiotics and probiotics. However, the U.S. is expected to be a potential market for the growth of this region in the forecast period.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), and ViThera Pharmaceuticals (U.S.)

Scope of the Report

Particulars

Scope

Geography

  • North America
    • U.S.
    • Canada
  • Europe
  • APAC
  • RoW

Historical Years

-

Base Year

2019

Forecast Period

2019-2023

Revenue Currency

USD ($)

This research report categorizes the Global market into the following segments and sub-segments:

  • Human Microbiome Market, by Product
    • Probiotics
    • Prebiotics
    • Food
    • Medical Foods
    • Devices
    • Drugs
    • Other Probiotic supplements
  • Human Microbiome Market, by Application
    • Therapeutics
    • Diagnostics
  • Human Microbiome Market, by Disease
    • Obesity
    • Diabetes
    • Autoimmune Disorder
    • Cancer
    • Acute Diarrhea
    • Mental Disorder
    • Other (Cardiovascular, Metabolic Syndrome (Elevated Blood Lipids, High Bp, and Liver Diseases), Drug Metabolism, and Atopic Dermatitis)
  • Human Microbiome Research Spending Market, by Product
    • Instruments
      • Laboratory Instruments
      • Analyzers
    • Consumables
      • Kits
      • Reagents
  • Human Microbiome Research Spending Market, by Technology
    • Omics Technology
    • High-throughput Technology
    • Cell Culture Technology
    • Computational Tools

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
           2.2.3 Key Industry Insights
           2.2.4 Assumptions

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 31)
    4.1 Market Overview
    4.2 Geographic Analysis: Market, By Product
    4.3 Geographic Snapshot of the Market
    4.4Market, By Product, 2019 vs 2023
    4.5 Human Microbiome Research Spending Market, By Technology, 2015 vs 2020
    4.6 Life Cycle Analysis

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Therapy, an Emerging Market
                    5.3.1.2 Human Microbiome as A New Validated Target
                    5.3.1.3 Need for Early Disease Detection and Diagnosis Driving the Use of Microbiomes in Molecular Diagnostics
           5.3.2 Restraints
                    5.3.2.1 Lack of Expertise, Proper Detailed Research
                    5.3.2.2 Barriers to Prove Causal Link Between Dysbiosis and Disease
           5.3.3 Opportunities
                    5.3.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota May Boost Market Growth
                    5.3.3.2 Joint Ventures, Collaborations, & Partnerships
           5.3.4 Threats
                    5.3.4.1 Government Regulations
           5.3.5 Burning Issues
                    5.3.5.1 Abundant Opportunities in the Microbiome Field and Tremendous Research Investments
                    5.3.5.2 Development of Microbiome Therapeutic Products

6 Human Microbiome Market, By Product (Page No. - 44)
    6.1 Introduction
    6.2 Probiotics
    6.3 Foods
    6.4 Prebiotics
    6.5 Medical Foods
    6.6 Diagnostic Devices
    6.7 Drugs
    6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application (Page No. - 54)
    7.1 Introduction
    7.2 Therapeutics
    7.3 Diagnostics

8 Human Microbiome Market, By Disease (Page No. - 59)
    8.1 Introduction
    8.2 Acute Diarrhea
    8.3 Obesity
    8.4 Diabetes
    8.5 Autoimmune Disorders
    8.6 Cancer
    8.7 Mental Disorders
    8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. - 70)
    9.1 Introduction
    9.2 Instruments
           9.2.1 Laboratory Instruments
           9.2.2 Analyzers
    9.3 Consumables
           9.3.1 Kits
           9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. - 80)
     10.1 Introduction
     10.2 Cell Culture Technology
     10.3 High-Throughput Technology
     10.4 Omics Technology
     10.5 Computational Tools

11 Geographic Analysis (Page No. - 88)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 112)
     12.1 Overview
     12.2 Competitive Situation and Trends
             12.2.1 Agreements, Partnerships, and Collaborations
             12.2.2 Acquisitions & Expansions
             12.2.3 New Product Launches, Product Approvals, and Patents
             12.2.4 Other Developments

13 Company Profiles (Page No. - 119)
     13.1 Geographic Revenue Mix of the Three Market Players
     13.2 Enterome Bioscience
             13.2.1 Business Overview
             13.2.2 Financials
             13.2.3 Products Offered
             13.2.4 Recent Developments
             13.2.5 MnM View
     13.3 E.I. Du Pont De Nemours and Company
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Merck & Co., Inc.
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Metabiomics Corporation
             13.5.1 Business Overview
             13.5.2 Financials
             13.5.3 Products Offered
             13.5.4 Recent Developments
             13.5.5 MnM View
     13.6 Yakult Honsha Co., Ltd.
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
             13.6.4 MnM View
     13.7 Microbiome Therapeutics, Llc
             13.7.1 Business Overview
             13.7.2 Financials
             13.7.3 Products Offered
             13.7.4 Recent Developments
     13.8 Osel, Inc.
             13.8.1 Business Overview
             13.8.2 Financials
             13.8.3 Products Offered
             13.8.4 Recent Developments
     13.9 Second Genome, Inc.
             13.9.1 Business Overview
             13.9.2 Financials
             13.9.3 Products Offered
             13.9.4 Recent Developments
     13.10 Vithera Pharmaceuticals
             13.10.1 Business Overview
             13.10.2 Financials
             13.10.3 Products Offered
             13.10.4 Recent Developments
     13.11 Vedanta Biosciences, Inc.
             13.11.1 Business Overview
             13.11.2 Financials
             13.11.3 Products Offered
             13.11.4 Recent Developments

14 Appendix (Page No. - 140)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Introducing RT: Real-Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports


List of Tables (89 Tables)

Table 1 Use of Microbiome in Early Disease Detection and Diagnosis, A Key Driver to the Growth of the Market
Table 2 Lack of Proper Detailed Research Curbs Market Growth
Table 3 Significant Impact of Regulatory Authorities May Boost Market Growth
Table 4 Modification of Regulatory Pathways By the Fda May Hamper the Growth of the Market
Table 5 Market Size, By Product, 20192023 (USD Million)
Table 6 Market Size for Probiotics, By Region, 2019-2023 (USD Million)
Table 7 Human Microbiome Foods Market, By Region, 2019-2023 (USD Million)
Table 8 Market Size for Prebiotics, By Region, 2019-2023 (USD Million)
Table 9 Market Size for Medical Foods, By Region, 2019-2023 (USD Million)
Table 10 Market Size for Diagnostic Devices, By Region, 20192023 (USD Million)
Table 11 Market Size for Drugs, By Region, 20192023 (USD Million)
Table 12 Market Size for Other Probiotic Supplements, By Region, 2019-2023 (USD Million)
Table 13 Market Size, By Application, 20192023 (USD Million)
Table 14 Market Size for Therapeutic Applications, By Region, 20192023 (USD Million)
Table 15 Market Size for Diagnostic Applications, By Region, 20192023 (USD Million)
Table 16 Market Size, By Disease, 20192023 (USD Million)
Table 17 Market Size for Acute Diarrhea, By Region, 20192023 (USD Million)
Table 18 Market Size for Obesity, By Region, 20192023 (USD Million)
Table 19 Market Size for Diabetes, By Region, 20192023 (USD Million)
Table 20 Market Size for Autoimmune Disorders, By Region, 20192023 (USD Million)
Table 21 Market Size for Cancer, By Region, 20192023 (USD Million)
Table 22 Market Size for Mental Disorders, By Region, 20192023 (USD Million)
Table 23 Market Size for Other Diseases, By Region, 20192023 (USD Million)
Table 24 Human Microbiome Research Spending Market Size, By Product, 20132020 (USD Million)
Table 25 Human Microbiome Research Spending Market Size for Instruments, By Type, 20132020 (USD Million)
Table 26 Market Size for Instruments, By Region, 20132020 (USD Million)
Table 27 North America: Market Size for Instruments, By Country, 20132020 (USD Million)
Table 28 Market Size for Laboratory Instruments, By Region, 20132020 (USD Million)
Table 29 North America: Market Size for Laboratory Instruments, By Country, 20132020 (USD Million)
Table 30 Human Microbiome Research Spending Market Size for Analyzers, By Region, 20132020 (USD Million)
Table 31 North America: Market Size for Analyzers, By Country, 20132020 (USD Million)
Table 32 Size for Consumables, By Type, 20132020 (USD Million)
Table 33 Market Size for Consumables, By Region, 20132020 (USD Million)
Table 34 North America: Market Size for Consumables, By Country, 20132020 (USD Million)
Table 35 Market Size for Kits, By Region, 20132020 (USD Million)
Table 36 North America: Human Microbiome Research Spending Market Size for Kits, By Country, 20132020 (USD Million)
Table 37 Market Size for Reagents, By Region, 20132020 (USD Million)
Table 38 North America: Market Size for Reagents, By Country, 20132020 (USD Million)
Table 39 Market Size, By Technology, 20132020 (USD Million)
Table 40 Market Size for Cell Culture Technology, By Region, 20132020 (USD Million)
Table 41 North America: Human Microbiome Research Spending Market Size for Cell Culture Technology, By Country, 20132020 (USD Million)
Table 42 Market Size for High-Throughput Technology, By Region, 20132020 (USD Million)
Table 43 North America: Market Size for High-Throughput Technology, By Country, 20132020 (USD Million)
Table 44 Market Size for Omics Technology, By Region, 20132020 (USD Million)
Table 45 North America: Market Size for Omics Technology, By Country, 20132020 (USD Million)
Table 46 Market Size for Computational Tools, By Region, 20132020 (USD Million)
Table 47 North America: Human Microbiome Research Spending Market Size for Computational Tools, By Country, 20132020 (USD Million)
Table 48 Human Microbiome Market Size, By Region, 20192023 (USD Million)
Table 49 Human Microbiome Research Spending Market Size, By Region, 20132020 (USD Million)
Table 50 North America: Human Microbiome Market Size, By Product, 20192023 (USD Million)
Table 51 North America: Human Microbiome Market Size, By Application, 20192023 (USD Million)
Table 52 North America: Human Microbiome Market Size, By Disease, 20192023 (USD Million)
Table 53 North America: Human Microbiome Research Spending Market Size, By Product, 20132020 (USD Million)
Table 54 North America: Human Microbiome Research Spending Market Size for Instruments, By Type, 20132020 (USD Million)
Table 55 North America: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 56 North America: Market Size, By Technology, 20132020 (USD Million)
Table 57 U.S.: Market Size, By Product, 20132020 (USD Million)
Table 58 U.S.: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 59 U.S.: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 60 U.S.: Market Size, By Technology, 20132020 (USD Million)
Table 61 Canada: Spending Market Size, By Product, 20132020 (USD Million)
Table 62 Canada: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 63 Canada: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 64 Canada: Market Size, By Technology, 20132020 (USD Million)
Table 65 Europe: Human Microbiome Market Size, By Product, 20192023 (USD Million)
Table 66 Europe: Human Microbiome Market Size, By Application, 20192023 (USD Million)
Table 67 Europe: Human Microbiome Market Size, By Disease, 20192023 (USD Million)
Table 68 Europe: Human Microbiome Research Spending Market Size, By Product, 20132020 (USD Million)
Table 69 Europe: Market Size for Instruments, By Type, 20132020 (USD Million)
Table 70 Europe: Market Size for Consumables, By Type, 20132020 (USD Million)
Table 71 Europe: Market Size, By Technology, 20132020 (USD Million)
Table 72 Asia-Pacific: Human Microbiome Market Size, By Product, 20192023 (USD Million)
Table 73 Asia-Pacific: Human Microbiome Market Size, By Application, 20192023 (USD Million)
Table 74 Asia-Pacific: Human Microbiome Market Size, By Disease, 20192023 (USD Million)
Table 75 APAC: Human Microbiome Research Spending Market Size, By Product, 20132020 (USD Million)
Table 76 APAC: Human Microbiome Research Spending Market Size for Instruments, By Type, 20132020 (USD Million)
Table 77 APAC: Human Microbiome Research Spending Market Size for Consumables, By Type, 20132020 (USD Million)
Table 78 APAC: Human Microbiome Research Spending Market Size, By Technology, 20132020 (USD Million)
Table 79 RoW: Human Microbiome Market Size, By Product, 20192023 (USD Million)
Table 80 RoW: Human Microbiome Market Size, By Application, 20192023 (USD Million)
Table 81 RoW: Human Microbiome Market Size, By Disease, 20192023 (USD Million)
Table 82 RoW: Human Microbiome Research Spending Market Size, By Product, 20132020 (USD Million)
Table 83 RoW: Human Microbiome Research Spending Market Size for Instruments, By Type, 20132020 (USD Million)
Table 84 RoW: Human Microbiome Research Spending Market Size for Consumables, By Type, 20132020 (USD Million)
Table 85 RoW: Human Microbiome Research Spending Market Size, By Technology, 20132020 (USD Million)
Table 86 Agreements, Partnerships, and Collaborations , 20122015
Table 87 Acquisitions & Expansions, 2012-2015
Table 88 New Product Launches, Product Approvals, and Patents, 20122015
Table 89 Other Developments, 20122015


List of Figures (46 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Human Microbiome Market Snapshot (2019 vs 2023)
Figure 6 Probiotics Segment to Dominate the Human Microbiome Market During the Forecast Period
Figure 7 Consumables Segment to Witness the Highest Growth Rate in the Microbiome Research Spending Market From 2015 to 2020
Figure 8 Cell Culture Technologies to Dominate the Human Microbiome Research Spending Market in 2015
Figure 9 Geographical Snapshot of the Global Human Microbiome Market, 2019
Figure 10 Agreements, Partnerships, and Collaborations - Dominant Strategy Pursued By Market Players
Figure 11 Growing Prevalence of Lifestyle Diseases and Increasing Acceptance of Microbiome-Based Products are Major Growth Drivers
Figure 12 Pr0biotics Segment to Account for the Largest Share of the Market in 2019
Figure 13 North America Poised to Be the Fastest-Growing Market From 2019 to 2023
Figure 14 Prebiotics Segment Poised to Grow at the Highest CAGR From 2019 to 2023
Figure 15 Cell Culture Technologies Segment to Dominate the Microbiome Research Spending Technology Market in 2015
Figure 16 North America to Enter Exponential Growth Phase
Figure 17 Human Microbiome as A New Validated Target for Drug Development May Spur the Market
Figure 18 Funds Provided for Microbiome Research By Various Medical Research Agencies
Figure 19 Probiotics Expected to Dominate the Human Microbiome Market During the Forecast Period
Figure 20 Europe Will Account for the Largest Share of the Probiotics Market in 2019
Figure 21 North America Expected to Dominate the Human Microbiome Foods Market From 2019 to 2023
Figure 22 Inorganic Growth Strategies Between Companies Will Increase the Demand for Microbiome-Based Drugs in Europe
Figure 23 The Therapeutics Segment to Command the Largest Share of the Human Microbiome Applications Market By 2023
Figure 24 Europe to Account for the Largest Share of the Therapeutics Application Segment in 2019
Figure 25 Acute Diarrhea Expected to Be the Largest Disease Segment of the Human Microbiome Market in 2019
Figure 26 Europe is Estimated to Be the Largest Human Microbiome Market for Acute Diarrhea in 2019
Figure 27 Human Microbiome Market for Obesity is Expected to Witness Highest Growth Rate in North America During the Forecast Period
Figure 28 Instruments Segment to Dominate the Human Microbiome Research Spending Market, By Product
Figure 29 Europe to Account for the Largest Share of the Instruments Segment in 2015
Figure 30 North America to Witness the Highest Growth in the Consumables Market From 2015 to 2020
Figure 31 Cell Culture Technology Segment to Grow at the Highest Rate From 2015 to 2020
Figure 32 Europe to Account for the Largest Share of the Cell Culture Technology Segment in 2015
Figure 33 U.S. to Account for the Largest Share of the North American High-Throughput Technology Market By 2020
Figure 34 Canada to Grow at the Highest Rate During the Forecast Period
Figure 35 North America Will Be the Fasted-Growing Region in the Computational Tools Market From 2015 to 2020
Figure 36 Geographic Snapshot (2019): North America Will Be the Fastest-Growing Region By 2019
Figure 37 North America Shows High Growth Potential for the Human Microbiome Research Spending Market
Figure 38 Demand for Human Microbiome Will Be Fueled By Growing R&D and Rising Incidences of Lifestyle Diseases and Chronic Disorders
Figure 39 Europe: Market Snapshot
Figure 40 Prebiotics Segment to Grow at the Fastest Rate in the APAC Human Microbiome Product Market From 2019 to 2023
Figure 41 Cell Culture Technology is the Most Commonly Used Technology for Human Microbiome Research in 2015
Figure 42 Companies Adopted Agreements, Collaborations, and Partnerships as Their Key Growth Strategy Over the Last Three Years
Figure 43 Battle for Market Share: Agreements, Collaborations, and Partnerships - Key Growth Strategy Adopted By Players in the Human Microbiome Market
Figure 44 E.I. Du Pont De Nemours and Company: Company Snapshot
Figure 45 Merck & Co., Inc.: Company Snapshot
Figure 46 Yakult Honsha Co., Ltd.: Company Snapshot

The human microbiome market is segmented by application, disease, product, and geography while the human microbiome research spending market is broadly segmented by product and technology.

The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (20192023). The market is driven by growing incidences of unhealthy lifestyle diseases, and increase in occurrence of autoimmune disorders. However, government regulation and lack of detailed research may restrain the growth of this market to an extent. Investing in probiotic and prebiotic products, medical foods, drugs, and devices will prove fruitful for companies in the future.

The applications segment is further subdivided into therapeutics and diagnostics. Therapeutics may be the leading segment, owing to growing population and diseases. Currently, the diagnostics segment has fewer products in the pipeline than the therapeutics segment.

The products segment is subdivided into probiotics, prebiotics, foods, medical foods, other supplements, devices, and drugs. Growth in these segments will be majorly driven due to use of probiotics and prebiotics for maintaining gut flora to avoid lifestyle diseases.

The human microbiome research spending market, by product, is divided characterized into instruments and consumables. The instruments segment is further segmented into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to be the fastest- growing segment by 2020, owing to the repeated purchases of consumables as compared to instruments.

The human microbiome research spending market, by technology, is divided into cell culture technology, high- throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2015. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions.

The geographic analysis reveals that Europe will account for the largest share within the forecast period of 2019 to 2023, due to high acceptance of probiotic and prebiotic products. Asia is expected to be a profitable region for the human microbiome market and poised to grow at a healthy CAGR in the forecast period. North America will show a low market share; however, it is expected to grow at a high CAGR from 2019 to 2023.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult Honsha Co., Ltd. (Japan), E. I. Du Pont de Nemours and company (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome, Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences, Inc. (U.S.), Osel, Inc. (U.S.), and Merck & Co, Inc. (U.S.)

Human Microbiome Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo